Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/1995
08/03/1995CA2181376A1 Aralkylamino substituted azacyclic therapeutic agents
08/03/1995CA2180528A1 Inhibitors of geranylgeranyl-protein transferase
08/03/1995CA2179715A1 Use of vanadium molybdenum or tungsten complexes for controlling cellular proliferation
08/02/1995EP0664780A1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals
08/02/1995EP0664711A1 Peptide inhibitors of cellular adhesion
08/02/1995EP0664706A1 Protein kinase c inhibition and novel compound balanol
08/02/1995EP0664700A1 Treatment of cachexia and inhibition of il-6 activity
08/02/1995EP0664695A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection
08/02/1995CN1105993A Preparation of sustituted azole
08/02/1995CN1105991A Quinoline compounds
08/01/1995US5438141 Heteroaryl and haloaryl quinoline derivatives of cyclopropaneacetic acid as leukotriene antagonists
08/01/1995US5438067 Medetomidine preparations for transdermal administration
08/01/1995CA1336516C Acyl derivatives of 2-amino-4-substituted-5-hydroxy pyrimidines
07/1995
07/27/1995WO1995019978A1 Tetracyclic derivatives, process of preparation and use
07/27/1995WO1995019970A1 Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
07/27/1995WO1995019965A1 Synthetic matrix metalloprotease inhibitors and uses thereof
07/27/1995WO1995019961A1 Metalloproteinase inhibitors
07/27/1995WO1995019959A1 Amino acid derivatives and their use as phospholipase a2 inhibitors
07/27/1995WO1995019957A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
07/27/1995WO1995019956A1 Metalloproteinase inhibitors
07/27/1995WO1995019790A1 Humanized antibodies against leukocyte adhesion molecule vla-4
07/27/1995WO1995019774A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
07/27/1995WO1995019767A1 Guanylhydrazones for treating inflammatory conditions
07/27/1995CA2181709A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
07/27/1995CA2177372A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
07/27/1995CA2158760A1 Synthetic matrix metalloprotease inhibitors and uses thereof
07/27/1995CA2126361A1 Gene encoding cationic amino acid transporter protein
07/26/1995EP0664289A2 Isoquinolines
07/26/1995EP0664282A1 Biaryl phospholipase A2 inhibitors
07/26/1995EP0664127A2 Pharmaceutical compositions containing isoquinoline derivatives
07/26/1995EP0664125A1 Inhibition of myeloperoxidase activity
07/26/1995EP0663919A1 Pyrimidine bisphosphonate esters as anti-inflamatories
07/26/1995EP0663918A1 Pure enantiomers of phosphoric-acid esters as phospholipase-a2 inhibitors
07/26/1995EP0663916A1 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
07/26/1995EP0663839A1 Ibuprofen-h 2? antagonist combinations
07/26/1995EP0663819A1 Ibuprofen-caffeine combinations
07/26/1995EP0502092B1 Oral composition for the treatment of inflammatory bowel diseases
07/26/1995EP0416037B1 Superoxide dismutase analogs having novel binding properties
07/25/1995US5436401 Skin disorders
07/25/1995US5436369 Alicyclic phospholipase A2 inhibitors
07/25/1995US5436321 Antibodies to the lipopolysaccharide bonding opsonin septin
07/25/1995US5436258 Prevention of bone resorption
07/25/1995US5436247 Antiinflammatory agents or antiarthritic agents
07/25/1995US5436241 Topical anti-inflammatory compositions containing piroxicam
07/25/1995US5436233 Nervous system disorders
07/25/1995US5436162 Human manganese superoxide dismutase (hMn-SOD)
07/25/1995US5436154 Stable hybridoma cells and antigen-antibodies
07/25/1995CA1336431C Thiazolo(5,4-b)azepine compounds
07/20/1995WO1995019436A1 Mammalian monocyte chemoattractant protein receptors
07/20/1995WO1995019372A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
07/20/1995WO1995019362A1 Dihydro pyrazolopyrroles
07/20/1995WO1995019356A1 Endopeptidase 24.15 inhibitor
07/20/1995WO1995019344A1 Gem-disubstituted azacyclic tachykinin antagonists
07/20/1995CA2180746A1 Gem-disubstituted azacyclic tachykinin antagonists
07/19/1995EP0663393A1 Novel 3-amino/hydroxy-4- 4-benzoylphenylcarboxylamino/oxy -azepanes and their homologies as protein kinase inhibitors
07/19/1995EP0662957A1 1,4-disubstituted piperazines useful in the therapy of the asthma and of the inflammation of the respiratory tract
07/19/1995EP0662840A1 Pharmaceutical compositions and methods for treating cold symptoms
07/19/1995EP0662838A1 Method of treating rheumatoid arthritis with type ii collagen
07/19/1995EP0662834A1 Novel epoxide-containing compounds
07/19/1995EP0662831A1 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions
07/19/1995EP0662782A1 Pp14-based therapy
07/19/1995CN1105368A Corticosteroid 17-alkyl carbonate 21-|O¨-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds
07/19/1995CN1105363A Quinoline or quinazoline derivatives, their production and use
07/18/1995US5434248 Peptidyl derivatives as inhibitors of interleukin-1β converting enzyme
07/18/1995US5434186 Antiinflammatory agents
07/18/1995US5434183 Phospholipids containing omega-3-fatty acids
07/18/1995US5434178 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation
07/18/1995US5434160 Autoimmune diseases; prevention of excess cell proliferation or enzyme release
07/18/1995US5434158 Asthma
07/18/1995US5434151 Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
07/18/1995US5434150 Anticoagulants, cardiovascular disorders
07/18/1995US5434149 Phosphodiesterase inhibitors
07/18/1995US5434131 Chimeric CTLA4 receptor and methods for its use
07/18/1995US5433940 Synthetic molecules mimic action of hirudin by binding to both the low affinity anion-binding exosite and the catalytic site of thrombin
07/18/1995CA1336349C Nitrogenous polycyclic tripeptides, their preparation and pharmaceutical compositions containing them
07/18/1995CA1336323C Process for the preparation of anti-inflammatory pharmaceutical agents with an ibuprofen base, with elimination, in solution, of the bitter taste, burning of the throat and intestinal toxicity
07/13/1995WO1995018826A2 Purified primate ctla-8 antigens and related reagents
07/13/1995WO1995018820A1 Monomeric diols and phosphate linked oligomers formed therefrom
07/13/1995WO1995018819A1 Ligand that binds fas antigen
07/13/1995WO1995018799A1 Phenyl heterocycles as cox-2 inhibitors
07/13/1995WO1995018797A1 Novel serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide
07/13/1995WO1995018793A1 Novel heterocyclic compounds
07/13/1995WO1995018792A1 Pyrrolidine-containing monomers and oligomers
07/13/1995WO1995018620A1 Treatment using arachidonic acid metabolite and particulate formulations
07/13/1995WO1995018615A1 A method of treating neurogenic inflammation
07/13/1995WO1995018610A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
07/13/1995CA2180651A1 Phenyl heterocycles as cox-2 inhibitors
07/13/1995CA2180239A1 A method of treating neurogenic inflammation
07/13/1995CA2180238A1 Novel heterocyclic compounds
07/13/1995CA2180123A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
07/13/1995CA2179986A1 Treatment using arachidonic acid metabolite and particulate formulations
07/13/1995CA2179913A1 Novel serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide
07/13/1995CA2139391A1 Azepanes and homologs thereof
07/12/1995EP0662148A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor
07/12/1995EP0662003A1 Oligonucleotide modulation of cell adhesion
07/12/1995EP0661996A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses
07/12/1995EP0661992A1 Pharmaceutical formulations of interleukin-1 inhibitors
07/12/1995EP0661978A1 Arylmethylphosphonates and phosphonic acids useful as anti-inflammatory agents
07/12/1995CN1105016A Triglycerides
07/11/1995US5432181 Substituted heteroaryl analogs of 4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents